AMP flags mass job cuts to reverse sinking share price

Embattled financial services giant will slash costs and headcount by merging some operations across AMP Capital and AMP Australia.

| More on:
Man in business suit carries box of personal effects

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

AMP Limited (ASX: AMP) will reportedly cut as much as 30% of its workforce in some business units.

The share price for the investment giant has been in freefall for a couple of years. It was $5.43 in March 2018 but now sits at a sorry $1.30.

In that time AMP has gone through sexual harassment scandals and been busted for multiple fee-for-no-service and overcharging scams. It has churned through board members as a result.

This week staff were informed that two of its biggest divisions would have its duplicate operations merged.

Chief executive Francesco De Ferrari reportedly said in the memo that some sections could have 30% of its workforce lopped off.

The Motley Fool understands the percentage figure is speculative, but AMP did confirm the restructure.

"AMP has made changes to its teams that will centralise some business services," said a company spokesperson.

"Our focus is on continuing to reshape the organisation to drive efficiency and support the delivery of AMP's strategy to become a simpler, client-led organisation."

The changes involve its investment arm AMP Capital and the banking brand AMP Australia.

De Ferrari had already put in place a billion-dollar "transformation" plan last year to rejuvenate the company.

But this year new chair Debra Hazelton flagged it was looking at the possibility of carving up AMP for potential bidders.

The Australian Mutual Provident Society was established in 1849 as a non-profit mutual society. The company demutualised to list in 1998 and has a market capitalisation of $4.5 billion.

Despite the recent share price drop, AMP stocks are still trading at an astonishing 107 price to earnings (P/E) ratio.

Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »